Advanced search

Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.

Arthur Schleifer worked as Director of New Business Development at Caesars License Co. LLC, Chief Marketing Officer at Pinnacle Entertainment, Inc., and Chief Marketing Officer at Groundfloor Finance, Inc. He holds a Master's in Business Administration from Harvard University and an undergraduate degree from Tufts University.

Cristina Schleifer is currently working as a Principal at Southeastern Capital Partners LLC.
She completed her undergraduate degree from Emory University.

Mr. Norman Schleifer is Chief Operating & Financial Officer at Iguana Healthcare Management LLC.
He has extensive experience in hedge fund administration and financial management, and most recently served as the Chief Financial Officer and Chief Operating Officer of Sivik Global Healthcare, LLC, a global healthcare long/short equity hedge fund.
Prior to Sivik, he served in a similar capacity at Merlin Biomed Group, LLC, a healthcare long/ short equity hedge fund and private equity fund managed by Stuart Weisbrod.
From 1993 to 1999, Mr. Schleifer was the Chief Financial Officer for Oracle Partners, LP, a global healthcare long/short equity hedge fund.
In addition, he spent 9 years as Controller/Assistant Trader at Morgens, Waterfall, Vintiadis & Co, a New York-based long/short hedge fund.
Norman began his career at Harry Goodkin & Co, CPAs, where he served as the Senior Audit Manager for hedge funds.
Mr. Schleifer received his BS in Business Administration from Pace University.

Mark A.
Schleifer worked as a Senior Director of Network Engineering at Digex from 1994 to 2000 and as a Vice President of IP Engineering at Cogent Communications Group, Inc. from 2000 to 2011.

Scott Schleifer worked as a Director at Postmates LLC.